SEPT 2022Portfolio Company Good Therapeutics Acquired by Roche, Launches Spinout Company Bonum Therapeutics /*! elementor - v3.15.0 - 09-08-2023 */ .elementor-widget-image{text-align:center}.elementor-widget-image a{display:inline-block}.elementor-widget-image a img[src$=".svg"]{width:48px}.elementor-widget-image img{vertical-align:middle;display:inline-block} ST. LOUIS (September 7, 2022)Read the Press ReleaseGood Therapeutics – a RiverVest Venture Fund IV portfolio company – has entered into a definitive...

AUG 2022Teleflex to Acquire Portfolio Company Standard Bariatrics /*! elementor - v3.15.0 - 09-08-2023 */ .elementor-widget-image{text-align:center}.elementor-widget-image a{display:inline-block}.elementor-widget-image a img[src$=".svg"]{width:48px}.elementor-widget-image img{vertical-align:middle;display:inline-block} ST. LOUIS (August 22, 2022)Read the Press ReleaseST. LOUIS (August 22, 2022) – Standard Bariatrics – a RiverVest Venture Fund IV portfolio company – has entered into a...

AUG 2021Portfolio Company Amplyx Pharmaceuticals Acquired by Pfizer /*! elementor - v3.15.0 - 09-08-2023 */ .elementor-widget-image{text-align:center}.elementor-widget-image a{display:inline-block}.elementor-widget-image a img[src$=".svg"]{width:48px}.elementor-widget-image img{vertical-align:middle;display:inline-block} ST. LOUIS (August 26, 2021)Read the Press ReleaseNEW YORK–(BUSINESS WIRE)– Pfizer Inc. (NYSE: PFE) announced today that it has acquired Amplyx Pharmaceuticals, Inc., a privately-held company dedicated to...

MAR 2021What's next for RiverVest Venture Partners after raising its largest-ever investment fund /*! elementor - v3.15.0 - 09-08-2023 */ .elementor-widget-image{text-align:center}.elementor-widget-image a{display:inline-block}.elementor-widget-image a img[src$=".svg"]{width:48px}.elementor-widget-image img{vertical-align:middle;display:inline-block} ST. LOUIS (March 24, 2021)Read the Press ReleaseST. LOUIS, MO (Mar. 24, 2021) – From the St. Louis Business JournalRiverVest Venture Partners has...

MAR 2021RiverVest Venture Partners Closes $275 Million Life Sciences Fund /*! elementor - v3.15.0 - 09-08-2023 */ .elementor-widget-image{text-align:center}.elementor-widget-image a{display:inline-block}.elementor-widget-image a img[src$=".svg"]{width:48px}.elementor-widget-image img{vertical-align:middle;display:inline-block} ST. LOUIS (March 23, 2021)Oversubscribed fund to continue investing in high-impact biopharma and medical device innovationST. LOUIS (March 23, 2021) – RiverVest Venture Partners, a leading...

FEB 2021Pascal Krotee Joins RiverVest as Senior Associate /*! elementor - v3.15.0 - 09-08-2023 */ .elementor-widget-image{text-align:center}.elementor-widget-image a{display:inline-block}.elementor-widget-image a img[src$=".svg"]{width:48px}.elementor-widget-image img{vertical-align:middle;display:inline-block} ST. LOUIS (February 16, 2021)St. Louis, MO (Feb 16, 2021) – Life science venture capital firm RiverVest continues to expand its team with the addition of Pascal Krotee...

SEPT 2020RiverVest Expands Analyst and Marketing & Communications Teams /*! elementor - v3.15.0 - 09-08-2023 */ .elementor-widget-image{text-align:center}.elementor-widget-image a{display:inline-block}.elementor-widget-image a img[src$=".svg"]{width:48px}.elementor-widget-image img{vertical-align:middle;display:inline-block} ST. LOUIS (September 1, 2020)ST. LOUIS, MO (September 1, 2020) – Life science venture capital firm RiverVest has expanded its team with additions to the analyst and...

JULY 2019Life sciences VC RiverVest Expands Team with New Managing Director and Senior Associate /*! elementor - v3.18.0 - 04-12-2023 */ .elementor-widget-image{text-align:center}.elementor-widget-image a{display:inline-block}.elementor-widget-image a img[src$=".svg"]{width:48px}.elementor-widget-image img{vertical-align:middle;display:inline-block} ST. LOUIS (July 23, 2019)ST. LOUIS, MO (July 23, 2019) – Life sciences venture capital firm RiverVest Venture Partners today announced the...

MAY 2019RiverVest Mourns Passing of Co-Founder Andrew B. Craig III /*! elementor - v3.15.0 - 09-08-2023 */ .elementor-widget-image{text-align:center}.elementor-widget-image a{display:inline-block}.elementor-widget-image a img[src$=".svg"]{width:48px}.elementor-widget-image img{vertical-align:middle;display:inline-block} ST. LOUIS (May 24, 2019)We mourn the passing of our co-founder, partner and friend, Andrew B. Craig III. He was essential to RiverVest’s founding in 2000...

MAY 2019RiverVest Builds Another San Diego Based Biopharma Company /*! elementor - v3.15.0 - 09-08-2023 */ .elementor-widget-image{text-align:center}.elementor-widget-image a{display:inline-block}.elementor-widget-image a img[src$=".svg"]{width:48px}.elementor-widget-image img{vertical-align:middle;display:inline-block} ST. LOUIS (May 20, 2019)Read the Press ReleaseRiverVest Managing Director Niall O’Donnell is the CEO of Reneo Pharmacueticals, which recently announced a $50M series A financing in which RiverVest...

JAN 2019Sivan Weitzman Joins RiverVest Venture Partners as CFO /*! elementor - v3.15.0 - 09-08-2023 */ .elementor-widget-image{text-align:center}.elementor-widget-image a{display:inline-block}.elementor-widget-image a img[src$=".svg"]{width:48px}.elementor-widget-image img{vertical-align:middle;display:inline-block} ST. LOUIS (January 22, 2019)ST. LOUIS, MO (Jan. 22, 2019) – Life sciences venture capital firm RiverVest Venture Partners today announced that Sivan Weitzman has joined the firm as...

DEC 2018RiverVest Venture Partners Closes on Oversubscribed $184.4 Million Life Science Fund /*! elementor - v3.15.0 - 09-08-2023 */ .elementor-widget-image{text-align:center}.elementor-widget-image a{display:inline-block}.elementor-widget-image a img[src$=".svg"]{width:48px}.elementor-widget-image img{vertical-align:middle;display:inline-block} ST. LOUIS (December 18, 2018)ST. LOUIS, MO (Dec. 18, 2018) – Life sciences venture capital firm RiverVest Venture Partners today announced the final closing...

APR 2018RiverVest Venture Partners' Portfolio Company Securus Sold to Boston Scientific Represents 9th Exit from RiverVest Venture Fund II /*! elementor - v3.15.0 - 09-08-2023 */ .elementor-widget-image{text-align:center}.elementor-widget-image a{display:inline-block}.elementor-widget-image a img[src$=".svg"]{width:48px}.elementor-widget-image img{vertical-align:middle;display:inline-block} ST. LOUIS and CLEVELAND (April 3, 2018)ST. LOUIS and CLEVELAND (April 3, 2018) – RiverVest Venture Partners...

OCT 2017RiverVest Venture Partners Expands Scientific Advisory Board /*! elementor - v3.15.0 - 09-08-2023 */ .elementor-widget-image{text-align:center}.elementor-widget-image a{display:inline-block}.elementor-widget-image a img[src$=".svg"]{width:48px}.elementor-widget-image img{vertical-align:middle;display:inline-block} ST. LOUIS (October 25, 2017)ST. LOUIS, MO (Oct. 25, 2017)—RiverVest Venture Partners announced today that Ronald T. Borchardt, Ph.D. and Jared Rutter, Ph.D. have joined the life science venture capital firm’s Scientific...

DEC 2016St. Louis Venture Fund Makes $15 Million Bet on its Hometown /*! elementor - v3.15.0 - 09-08-2023 */ .elementor-widget-image{text-align:center}.elementor-widget-image a{display:inline-block}.elementor-widget-image a img[src$=".svg"]{width:48px}.elementor-widget-image img{vertical-align:middle;display:inline-block} ST. LOUIS (December 2, 2016)Read the Press ReleaseBy: David NicklausSource: St. Louis Post-DispatchDate: December 2, 2016When RiverVest Venture Partners opened its doors in 2000,...